Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 22-Nov-2022 titled Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
